Changmao Biochemical Engineering Co (HKSE:00954) Ending Cash Position : HK$109.5 Mil (As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Changmao Biochemical Engineering Co Ending Cash Position?

Changmao Biochemical Engineering Co's Ending Cash Position for the quarter that ended in Jun. 2023 was HK$109.5 Mil.

Changmao Biochemical Engineering Co's quarterly Ending Cash Position declined from Jun. 2022 (HK$133.6 Mil) to Dec. 2022 (HK$67.0 Mil) but then increased from Dec. 2022 (HK$67.0 Mil) to Jun. 2023 (HK$109.5 Mil).

Changmao Biochemical Engineering Co's annual Ending Cash Position declined from Dec. 2020 (HK$158.5 Mil) to Dec. 2021 (HK$71.2 Mil) and declined from Dec. 2021 (HK$71.2 Mil) to Dec. 2022 (HK$67.0 Mil).

Changmao Biochemical Engineering Co Ending Cash Position Historical Data

The historical data trend for Changmao Biochemical Engineering Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Ending Cash Position Chart

Changmao Biochemical Engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

132.77

158.48

71.24

67.00

Changmao Biochemical Engineering Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															71.24	133.57	67.00	109.52	-

Changmao Biochemical Engineering Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Changmao Biochemical Engineering Co's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	64.969	+	2.026
	=	67.0

Changmao Biochemical Engineering Co's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	65.619	+	43.903
	=	109.5

Changmao Biochemical Engineering Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Changmao Biochemical Engineering Co (HKSE:00954) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034

Website

http://www.cmbec.com.hk

Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.

Changmao Biochemical Engineering Co (HKSE:00954) Headlines

No Headlines